Christine Wilcox
Psychiatric/Mental Health · Centerville, MANPI 1730733189
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.1% of the total across 161 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 15 manufacturers, the largest accounting for just 16.9% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2024 at $883 and has fallen 64.3% since, to $315 in 2025. Among psychiatric/mental health clinicians in MA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 161 payments — averaging $21.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alkermes, Inc.$574
- AbbVie$539
- Otsuka America Pharmaceutical, Inc.$444
- Johnson & Johnson$389
- Lundbeck LLC$276
- Takeda Pharmaceuticals U.S.A., Inc.$263
- plus $911 from 9 others
What the payments were for
- Food & beverage$3,36699%
- Education$301%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alkermes, Inc. | 31 | $574 |
| AbbVie | 27 | $539 |
| Otsuka America Pharmaceutical, Inc. | 17 | $444 |
| Johnson & Johnson | 17 | $389 |
| Lundbeck LLC | 15 | $276 |
| Takeda Pharmaceuticals U.S.A., Inc. | 12 | $263 |
| Corium, LLC | 8 | $175 |
| Axsome Therapeutics, Inc. | 7 | $161 |
| Sunovion Pharmaceuticals Inc. | 7 | $149 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 6 | $118 |
| E.r. Squibb & Sons, L.L.C. | 4 | $98 |
| Teva Pharmaceuticals USA, Inc. | 4 | $73 |
| Vanda Pharmaceuticals Inc. | 2 | $64 |
| Braeburn Inc. | 3 | $55 |
| Sage Therapeutics, LLC | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- LYBALVI$500
- REXULTI$111
- INVEGA SUSTENNA$111
How this compares
$3,395 in reported general payments places this provider in the 90th percentile of 1,284 psychiatric/mental health providers in Massachusetts.
See all psychiatric/mental health providers in Massachusetts →
Other psychiatric/mental health in Centerville
- Brianne LienkampMarion$121K
- Ashley BakerQuincy$54K
- Brian BanksPembroke$47K
- Anne-Margaret BotelhoMattapoisett$46K
- Matthew PeculisWalpole$41K
- Sherrie UrenaWorcester$21K
- Irina DauphineeHanover$18K
- Schree PettigrewNew Bedford$18K
- Sherryl RosenLynn$16K
- Kevin NardoneWorcester$16K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.